Breno Gonçalves da Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Breno Gonçalves da Silva has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ana Beatriz Monteiro Fonseca
Universidade Federal Fluminense, Brazil
1 shared publication - Cynthia Boschi-Pinto
Universidade Federal Fluminense, Brasil
1 shared publication - Daniel Alejandro Encalada
Hospital São Francisco na Providência de Deus, Brazil
1 shared publication - Eduardo Pinho Braga
Hospital São Francisco na Providência de Deus, Brazil
1 shared publication - Fernando de Barros
Universidade Federal Fluminense, Brazil
1 shared publication - Guilherme Marins Lima Sousa
Universidade Federal Fluminense, Brasil
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 39
Waiting time for bariatric and metabolic surgery in the Brazilian public health system and comorbidities: what is the impact?
Background: Obesity is a multifactorial disease with a high prevalence that leads to several comorbidities, posing significant challenges for healthcare systems. Bariatric and metabolic surgery (BMS) has been established as the most effective treatment for patients with obesity; however, in Brazil, limited access remains a critical barrier. Aims: This study aimed to evaluate the clinical, demographic, and metabolic characteristics of patients with obesity undergoing BMS in the Brazilian Unified Health System and to analyze the relationship between waiting time and comorbidities. Methods: A retrospective cohort study was conducted involving 1,000 patients with obesity who underwent treatment between July 2022 and June 2024. Clinical, anthropometric, and laboratory variables were analyzed using regression analysis and statistical tests to assess the association between waiting time and comorbidities. Results: A significant correlation was found between prolonged waiting time and an increased number of comorbidities (R²=0.686; p<0.001). Furthermore, the number of comorbidities explained 60% of the variability in waiting time (R²=0.600; p<0.001), with a mean increase of 1.92 years for each additional comorbidity (95%CI 1.82–2.02). Patients on the waiting list for more than 10 years had higher rates of hypertension, type 2 diabetes, and dyslipidemia. Waiting time also had an impact on some metabolic syndrome parameters, including glycated hemoglobin (Hb1Ac) (r=+680, p=0.031), low-density lipoprotein (LDL) (r=+640, p=0.044), and total cholesterol (r=+830, p=0.008). Conclusions: Prolonged waiting time for bariatric and metabolic surgery is associated with an increased burden of metabolic comorbidities and their consequences.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 39
Open AccessWaiting time for bariatric and metabolic surgery in the Brazilian public health system and comorbidities: what is the impact?
Background: Obesity is a multifactorial disease with a high prevalence that leads to several comorbidities, posing significant challenges for healthcare systems. Bariatric and metabolic surgery (BMS) has been established as the most effective treatment for patients with obesity; however, in Brazil, limited access remains a critical barrier. Aims: This study aimed to evaluate the clinical, demographic, and metabolic characteristics of patients with obesity undergoing BMS in the Brazilian Unified Health System and to analyze the relationship between waiting time and comorbidities. Methods: A retrospective cohort study was conducted involving 1,000 patients with obesity who underwent treatment between July 2022 and June 2024. Clinical, anthropometric, and laboratory variables were analyzed using regression analysis and statistical tests to assess the association between waiting time and comorbidities. Results: A significant correlation was found between prolonged waiting time and an increased number of comorbidities (R²=0.686; p<0.001). Furthermore, the number of comorbidities explained 60% of the variability in waiting time (R²=0.600; p<0.001), with a mean increase of 1.92 years for each additional comorbidity (95%CI 1.82–2.02). Patients on the waiting list for more than 10 years had higher rates of hypertension, type 2 diabetes, and dyslipidemia. Waiting time also had an impact on some metabolic syndrome parameters, including glycated hemoglobin (Hb1Ac) (r=+680, p=0.031), low-density lipoprotein (LDL) (r=+640, p=0.044), and total cholesterol (r=+830, p=0.008). Conclusions: Prolonged waiting time for bariatric and metabolic surgery is associated with an increased burden of metabolic comorbidities and their consequences.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 31 (6)
Tendência da razão de mortalidade materna segundo raça/cor no estado do Rio de Janeiro, Brasil, 2008 a 2021
Resumo A morte materna é um grave problema de saúde pública, e o estado do Rio de Janeiro apresenta os piores indicadores da região Sudeste. O objetivo do estudo é analisar a tendência da mortalidade materna geral e por principais causas, de acordo com a raça/cor, no estado do Rio de Janeiro (RJ) durante o período de 2008 a 2021. É um estudo ecológico de tendência temporal com dados secundários dos sistemas de informações em saúde. A classificação de causas de morte materna foi a ICD-MM da OMS. Foi estimada a mudança percentual anual, usando o modelo de regressão joinpoint. No período ocorreram 2.522 óbitos maternos, com razão de mortalidade materna (RMM) variando de 81,6 a 131,9 para cada 100.000 nascidos vivos no biênio pandêmico. O padrão temporal predominante foi de estabilidade para RMM total e por cor, exceto para pardas, cuja RMM foi decrescente entre 2008 e 2016. Evidenciaram-se desigualdades raciais, com as maiores RMM pertencendo às mulheres pretas, independentemente da causa de morte. O cenário atual ainda se encontra muito distante daquele proposto pelo Ministério de Saúde, de 30/100.000 NV até 2030, com destaque especial para a influência da pandemia e das desigualdades raciais nos indicadores de saúde.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 31 (6)
Open AccessTendência da razão de mortalidade materna segundo raça/cor no estado do Rio de Janeiro, Brasil, 2008 a 2021
Resumo A morte materna é um grave problema de saúde pública, e o estado do Rio de Janeiro apresenta os piores indicadores da região Sudeste. O objetivo do estudo é analisar a tendência da mortalidade materna geral e por principais causas, de acordo com a raça/cor, no estado do Rio de Janeiro (RJ) durante o período de 2008 a 2021. É um estudo ecológico de tendência temporal com dados secundários dos sistemas de informações em saúde. A classificação de causas de morte materna foi a ICD-MM da OMS. Foi estimada a mudança percentual anual, usando o modelo de regressão joinpoint. No período ocorreram 2.522 óbitos maternos, com razão de mortalidade materna (RMM) variando de 81,6 a 131,9 para cada 100.000 nascidos vivos no biênio pandêmico. O padrão temporal predominante foi de estabilidade para RMM total e por cor, exceto para pardas, cuja RMM foi decrescente entre 2008 e 2016. Evidenciaram-se desigualdades raciais, com as maiores RMM pertencendo às mulheres pretas, independentemente da causa de morte. O cenário atual ainda se encontra muito distante daquele proposto pelo Ministério de Saúde, de 30/100.000 NV até 2030, com destaque especial para a influência da pandemia e das desigualdades raciais nos indicadores de saúde.